After-hours top loser: 1332.HK Touyun Biotech (HKSE) down 58%, liquidity flag
1332.HK stock plunged sharply after hours on 26 Jan 2026, sliding to HK$0.109 on heavy turnover. The share price fell 58.08% from the previous close, driven by a 31,270,000 share print that dwarfed the 50-day average. This move made Touyun Biotech Group Limited one of the session’s top losers on the HKSE in Hong Kong and raises near-term liquidity and solvency questions for investors watching the packaging and biotech segments.
Session snapshot: 1332.HK stock after-hours sell-off
Touyun Biotech Group Limited (1332.HK) closed the regular session near HK$0.26 and then traded HK$0.109 after hours on 26 Jan 2026, a -58.08% intraday shift. Volume for the day hit 31,270,000 shares versus an average of 5,143,099, a relative volume surge of 103.78x that confirms heavy selling pressure.
Financial and valuation metrics for 1332.HK stock
At the after-hours price of HK$0.109, Touyun Biotech’s market cap is about HK$283,364,792.00 on the HKSE in Hong Kong. The company shows EPS -0.01 and PE -10.10, a negative earnings base that limits traditional valuation. Liquidity and solvency ratios are weak: current ratio 0.20 and book value per share -0.00 indicate tight short-term coverage and negative equity per share metrics.
Technical picture and trading signals for 1332.HK stock
Momentum indicators show oversold conditions: RSI 39.52, CCI -129.98, and Williams %R -90.36. Price sits well below the 50-day average HK$0.27 and near the 200-day HK$0.16, signalling a clear downtrend. High intraday volume and a spike in on-balance volume reflect distribution and limited buy-side support in the short term.
Meyka Grade and forecast for 1332.HK stock
Meyka AI rates 1332.HK with a score out of 100: 60.15 (Grade B, Suggestion: HOLD). This grade factors S&P 500 and sector comparisons, financial growth, key metrics, and analyst consensus. Meyka AI’s forecast model projects a yearly level at HK$0.125294 and a quarterly projection at HK$0.27. Versus the current price HK$0.109, the yearly model implies an upside of 14.95% while the quarterly scenario implies 147.70% upside. Forecasts are model projections and not guarantees.
Risks and catalysts affecting 1332.HK stock
Principal risks include negative equity metrics, tight current liquidity, a long cash conversion cycle with days sales outstanding 200.05, and high debt-to-market-cap 1.41. Catalysts that could stabilize the stock are stronger QR code or packaging orders, clearer results from treasury investments, or a near-term corporate update that narrows receivables and restores working capital.
Price targets and what traders should watch for 1332.HK stock
Absent a consensus price target, scenario targets help frame risk. A conservative downside floor sits near the year low HK$0.067; a short-term technical recovery target is HK$0.20, and a bullish rebound scenario matches Meyka’s quarterly model at HK$0.27. Watch admissions of capital needs, changes in receivables aging, and daily volume spikes above 5,143,099 for confirmation.
Final Thoughts
Key takeaways: 1332.HK stock is a clear after-hours top loser on 26 Jan 2026 after tumbling to HK$0.109 on -58.08% price change and heavy 31,270,000 share turnover. Financials show negative EPS -0.01, a negative price-to-book dynamic, and a fragile current ratio 0.20, which together raise solvency and liquidity concerns for short-term holders. Meyka AI rates 1332.HK with a score out of 100 at 60.15 (Grade B, HOLD) and flags mixed signals: our yearly forecast HK$0.125294 implies ~14.95% upside, while a quarterly recovery scenario suggests materially higher gains. Investors should treat forecasts as model-based projections, not certainties. For active traders, look for a sustained volume drop and improving working capital before considering scale-in. For longer-term investors, a clear recovery in receivables and stronger operating cash flow would be required to justify re-rating in the consumer cyclical packaging sector in Hong Kong. For company filings and corporate notices consult the company site and HKEX company announcements for confirmed updates. Company website | HKEX announcements search
FAQs
Why did 1332.HK stock drop so sharply after hours?
The after-hours drop to HK$0.109 reflects heavy selling and a 31,270,000 share session that overwhelmed typical liquidity. Weak short-term ratios, negative EPS, and investor concern about working capital likely triggered the move.
What is Meyka AI’s view and score for 1332.HK stock?
Meyka AI rates 1332.HK with a score out of 100 at 60.15 (Grade B, Suggestion: HOLD). The grade balances sector metrics, financial growth, and forecasts; it is informational and not investment advice.
What price targets and upside does the forecast show for 1332.HK stock?
Meyka AI’s forecast model projects HK$0.125294 yearly and HK$0.27 quarterly. Versus the current HK$0.109, the yearly implies ~14.95% upside and the quarterly implies ~147.70% in a recovery case.
What key indicators should traders watch for 1332.HK stock?
Monitor daily volume relative to the 5,143,099 average, improvements in current ratio above 1.0, receivables aging, and RSI moving above 50. Confirming lower volatility and steady cashflow are also critical.
Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.
